Skip to main content
. Author manuscript; available in PMC: 2019 Jun 19.
Published in final edited form as: Clin Cancer Res. 2019 Jan 22;25(8):2644–2655. doi: 10.1158/1078-0432.CCR-18-1401

Table 1.

Clinicopathological characteristics of 104 PanNET patients who underwent to surgery at MGH between 1995 and 2012.

                 Median (IQR) Number (%)

Gender
Male 53 (51)
Female 51 (49)
Age at surgery, year             55 (47–63)
Race
Caucasian 90 (86)
African American 6 (6)
Hispanic 4 (4)
Asian 3 (3)
Other 1 (1)
CACI                     3 (1–5)
Functional
Yes 9 (9)
No 95 (91)
Tumor size, cm               2.8 (2.0–4.5)
WHO grade
1 57 (55)
2 47 (45)
Mitotic count /10HPF             0.2 (0.0–2.0)
Ki67 labeling index, %              2.0 (1.2–3.2)
T stage
1 27 (26)
2 59 (57)
3 16 (15)
4 2 (2)
Lymph node positivity
Yes 18 (17)
No 86 (83)
Clavien-Dindo grade (90 days)
0-II 84 (81)
III-V 20 (19)

IQR: interquartile range; CACI: Charlson Age Comorbidity Index; HPF: high-power field